← All trials
NCT04981314
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 18, 2021
- Primary completion
- Oct 1, 2021
- Completion date
- Oct 31, 2021
- First posted
- Jul 29, 2021
- Last posted
- Aug 10, 2021
- Enrollment
- 230
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Santiago de CompostelaLead sponsor
- University of Santiago de CompostelaSponsor investigator
- SALUD (Servicio Aragonés de Salud), SpainStudy chair
- Laboratoires ArkopharmaCollaborator
- SALUD (Servicio Aragonés de Salud), SpainCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.